Key Points

  • Lufthansa reported a stronger-than-expected operating profit for 2025.
  • Cost controls and fleet modernization helped improve margins.
  • The airline warned that geopolitical tensions could cloud the outlook for 2026.
hero

Lufthansa reported stronger-than-expected financial results for 2025, as tighter financial management and ongoing fleet modernization helped improve operational efficiency.

The airline group posted an adjusted operating profit of €2 billion, surpassing analyst expectations of approximately €1.9 billion. The result marked a notable increase from the €1.6 billion operating profit recorded in 2024.

Profitability Improves as Costs Stabilize

Lufthansa’s operating profit margin rose to 4.9% in 2025, compared with 4.4% in the previous year.

Management credited stricter cost controls and improvements in fleet efficiency for helping offset industry pressures such as rising operational costs and fluctuating travel demand.

The company has been gradually renewing aircraft across its network in an effort to lower fuel consumption and improve long-term profitability.

Long-Term Margin Goals Remain Ambitious

Despite the improvement, Lufthansa’s current profitability remains well below its long-term targets.

The airline aims to increase operating margins to between 8% and 10% between 2028 and 2030, a significant jump from the current level.

However, labor disruptions have created obstacles to achieving those targets. A strike on February 12 highlighted ongoing tensions that can disrupt flight schedules and impact profitability.

Geopolitical Tensions Cloud 2026 Outlook

While the company expects moderate expansion, Lufthansa acknowledged that the outlook for 2026 remains uncertain.

Geopolitical tensions — particularly those affecting travel demand and airspace operations — are adding unpredictability to the airline industry.

The company still projects capacity growth of around 4% next year, along with increases in revenue and operating margins, though management cautioned that external risks could influence performance.

Airlines Navigate Volatile Global Environment

Airlines worldwide are facing a complex operating environment shaped by geopolitical instability, labor challenges, and fluctuating fuel costs.

Carriers must balance capacity expansion with cost discipline while adapting to changes in global travel demand.

For Lufthansa, maintaining profitability improvements while navigating these risks will be a key focus as it works toward its longer-term margin goals.


Comparison, examination, and analysis between investment houses

Leave your details, and an expert from our team will get back to you as soon as possible

    * This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.

    To read more about the full disclaimer, click here
    SKN | Ceconomy Board to Meet March 12 as CEO Departure and JD.com Takeover Progress
    • omer bar
    • 4 Min Read
    • ago 8 minutes

    SKN | Ceconomy Board to Meet March 12 as CEO Departure and JD.com Takeover Progress SKN | Ceconomy Board to Meet March 12 as CEO Departure and JD.com Takeover Progress

    Ceconomy said its supervisory board will meet on March 12 to discuss the company’s next steps following the announcement that

    • ago 8 minutes
    • 4 Min Read

    Ceconomy said its supervisory board will meet on March 12 to discuss the company’s next steps following the announcement that

    SKN | China Approves Pfizer GLP-1 Weight Loss Drug as Obesity Treatment Market Expands
    • sagi habasov
    • 5 Min Read
    • ago 39 minutes

    SKN | China Approves Pfizer GLP-1 Weight Loss Drug as Obesity Treatment Market Expands SKN | China Approves Pfizer GLP-1 Weight Loss Drug as Obesity Treatment Market Expands

    Pfizer has received regulatory approval in China for its GLP-1 receptor agonist drug Xianweiying, marking the company’s entry into the

    • ago 39 minutes
    • 5 Min Read

    Pfizer has received regulatory approval in China for its GLP-1 receptor agonist drug Xianweiying, marking the company’s entry into the

    SKN | Foreign Investors Pull Billions From Indian IT Stocks Amid AI Disruption Fears
    • Lior mor
    • 5 Min Read
    • ago 2 hours

    SKN | Foreign Investors Pull Billions From Indian IT Stocks Amid AI Disruption Fears SKN | Foreign Investors Pull Billions From Indian IT Stocks Amid AI Disruption Fears

    Foreign portfolio investors sharply reduced exposure to India’s technology sector in February as concerns grew that rapid advances in artificial

    • ago 2 hours
    • 5 Min Read

    Foreign portfolio investors sharply reduced exposure to India’s technology sector in February as concerns grew that rapid advances in artificial

    SKN | Shanghai Henlius Biotech Draws Attention After Abbott Licensing Expansion
    • omer bar
    • 6 Min Read
    • ago 11 hours

    SKN | Shanghai Henlius Biotech Draws Attention After Abbott Licensing Expansion SKN | Shanghai Henlius Biotech Draws Attention After Abbott Licensing Expansion

    Shanghai Henlius Biotech has attracted renewed investor attention after expanding its licensing agreement with Abbott, potentially unlocking new markets for

    • ago 11 hours
    • 6 Min Read

    Shanghai Henlius Biotech has attracted renewed investor attention after expanding its licensing agreement with Abbott, potentially unlocking new markets for